CompletedPhase 1NCT00526916

PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28

Studying Cysticercosis

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Institute of Mental Health (NIMH)
Principal Investigator: Masahiro Fujita, M.D.
National Institute of Mental Health (NIMH)
Intervention: [C-11]PBR28(drug)
Enrollment: 18 enrolled
Eligibility: 18-75 years · All sexes
Timeline: 2007 – 2014

Study locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00526916 on ClinicalTrials.gov

Other trials for Cysticercosis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT00001205
Natural History of Treated Neurocysticercosis and Long-Term Outcomes
National Institute of Allergy and Infectious Diseases (NIAID)

See all trials for Cysticercosis →

← Back to all trials